Status:
COMPLETED
Research and Characterization of New Genes Involved in Intellectual Disability
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Intellectual Disability
Eligibility:
All Genders
Brief Summary
Intellectual disability (ID) occurs in 2 to 3 % of the general population but the cause is identified only in 30 to 60% of cases. The purpose of this study is to indentify genes involved in ID with n...
Eligibility Criteria
Inclusion
- for the patients: Clinical diagnosis of intellectual disbility
- for the unaffected sibs: to be aged at least 3 years
- informed consent
Exclusion
- absence of informed consent
Key Trial Info
Start Date :
December 31 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
8500 Patients enrolled
Trial Details
Trial ID
NCT01867554
Start Date
December 31 2012
End Date
December 31 2022
Last Update
January 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CRICM - UPMC/Inserm UMR_S975/CNRS UMR7225, Groupe Hospitalier de la Pitié-Salpêtrière,
Paris, France, 750013